Nautilus Biotechnology, Inc. (NAUT) stock
Close on Nov 12, 2026Market cap $303.15MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026
Valuation
- Market cap
- $303.15M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.60
- Dividend yield
- –
- Free cash flow yield
- -18.19%
Fundamentals
- Net income
- -$58.58M
- EPS, diluted
- -$0.46
- Free cash flow
- -$55.14M
- Book value per share
- $0.92
- Diluted shares
- 127M
Trading
- Next earnings
- Feb 25, 2027 (estimated, during market hours)
- Previous close
- $2.42
- Open
- $2.40
- Day's range
- $2.24 – $2.46
- Volume
- 3,318,404
- Average volume (20 days)
- 8,698,966
- Index membership
- Russell 2000 (since Jun 2026)
- Beta (5 years)
- 1.31
- 52-week range
- $0.84 – $4.31
- RSI (14 days)
- 51.9
- Volatility (1 year)
- 117.3%
- Relative volume
- 0.74×
- WACC
- 11.5%
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | NAUT | S&P 500 | Difference | NAUT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +9.7% | -2.7% | +12.4 pts | ||
| 3 months | +164.5% | -1.7% | +166.3 pts | ||
| Year to date | +22.1% | +11.9% | +10.2 pts | ||
| 1 year | +37.6% | +12.0% | +25.6 pts | ||
| 3 years | -10.2% | +78.2% | −88.4 pts | -3.5% | +21.2% |
| 5 years | -54.1% | +73.2% | −127.4 pts | -14.4% | +11.6% |
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Net income
EPS, diluted
Free cash flow
Press releases
Releases Nautilus Biotechnology filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Nautilus Biotechnology
Laboratory Analytical Instruments
Nautilus Biotechnology is a development-stage life sciences company that develops platform technology for single-molecule proteomic analysis. The company's core offering is the Nautilus Voyager platform, an end-to-end system that combines nanofabricated protein arrays, instruments, consumables, and machine-learning software to measure protein abundance and functional variants using its iterative mapping technique. Its applications encompass broadscale proteome profiling and targeted proteoform analysis, alongside fee-for-service proteomics analysis offerings. Nautilus serves researchers at biopharmaceutical companies, academic institutions, and research organizations.
Company profile, executives and historyNautilus Biotechnology stock: common questions
What is Nautilus Biotechnology's stock price?
NAUT closed at $2.38 on Nov 12, 2026, down 1.65% on the day. Over the past 52 weeks it traded between $0.84 and $4.31.
What is Nautilus Biotechnology's market cap?
Nautilus Biotechnology was worth $303.15M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is NAUT's P/E ratio?
Nautilus Biotechnology lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.46), so it has no meaningful P/E ratio.
Does Nautilus Biotechnology pay a dividend?
No. Nautilus Biotechnology has not paid a cash dividend over the last twelve months.
When does Nautilus Biotechnology report earnings next?
Nautilus Biotechnology is expected to report Q4 FY2026 results on Feb 25, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has NAUT stock performed over the past year?
Including dividends, NAUT returned +37.6% over the past year, against +12.0% for the S&P 500.
How many NAUT shares are sold short?
6M shares were sold short at the latest FINRA report, 8.36% of the float, or 1.0 days of average trading volume.
Who are Nautilus Biotechnology's competitors?
Companies most similar to Nautilus Biotechnology by business, industry and size include SEER, TXG, QTRX, A, HBIO.
See a number that looks wrong?